… atherosclerosis development in hypertensive individuals and that low levels of anti-PC
independently predict development … -PC ameliorate atherosclerosis development. The possibility …

… p-nitrophenyl phosphorylcholine (NPPC) whereas Group II antibodies require the phenyl …
anti-PC antibodies with focus on anti-inflammation in atherosclerosis. After developing a …

… Already in the 1970s, Russell Ross hypothesized that a ‘response to injury’ was essential
in atherosclerosis development and the discussed potential underlying factors are compatible …

… atherosclerosis, which is the main topic herein, not only because CVD and atherosclerosis …
because much more is known about phosphorylcholine (PC) and antibodies against PC (anti-…

… Active PC immunization resulted in activation of the B-cell compartment in parallel with
enrichment of B cells and T15-like antibodies within the atherosclerotic plaques where their …

… IgM antibodies against phosphorylcholine (anti-PC) are protection factors for atherosclerosis
… house ELISA [3], and it is possible that low levels of such antibodies predispose to CVD [2]. …

… to develop a monoclonal PC IgG antibody with anti-inflammatory and anti-atherosclerotic …
The current project aimed to develop a fully human monoclonal PC antibody (PC-mAb) for the …

… It is thus important to emphasize that PC is not exposed to any significant degree in the
normal artery, which occurs much more in arteries where atherosclerosis is developing. …

… of CVD and atherosclerosis. We recently reported a negative association between levels
of antibodies against phosphorylcholine (anti-PC) IgM and development of atherosclerosis in …

… Natural antibodies specific for phosphorylcholine (anti-PC) have been implicated as
protective factors in atherosclerosis. We herein determined the relationship between IgM anti-PC …